The final rules were submitted Sept. 3 and are listed as “pending review” in the OMB’s list of regulatory actions.
Some of the key changes for the 2015-2017 modification rule include a 90-day reporting period instead of the current one-year reporting period, as well as revised stage 2 requirements offering providers certain exemptions and flexibilities.
Proposed rules for stage 3 of the meaningful use program are slated to be the final stage of the Federal EHR Incentive Program. As currently proposed, all providers would begin attesting to stage 3 in 2018, regardless of their current stage.
More articles on meaningful use:
Has MU failed its mission?
Hospital groups urge HHS to finalize MU Stage 2 rules
15 thoughts on interoperability from healthcare leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.